BioSpace News Archive

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX ® in North America , today announced the appointment of Joseph Truitt as Chief Executive Officer. Mr. Truitt was appoint

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest

TORONTO, May 11, 2020 /PRNewswire/ - Portage Biotech Inc., is pleased to announce that it has made an additional €900k investment in its associate, Stimunity, the Paris-based cancer immunotherapy company focused on STING.

Reported positive top-line data from AXA1125-003, with clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation observed in subjects with NAFLD receiving AXA1125 Completed enrollment of AXA1665-002, with data readout expected in Q3 2020 Announced AXA2678 patent issuance and oral presentation at ICSFR Launched new corporate website at www.axcellahealth.com CAMBRIDGE, Mass.--( BUSINE

Decibel Therapeutics to Present at the 23 rd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

New diagnostic system will combine whole-genome sequencing and machine learning to identify a pathogen and its drug-resistance profile within hours, not days

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that management will present company overviews at the following conferences being held virtually:

Vasomune Therapeutics, Inc., a therapeutic biopharmaceutical company developing a novel first-in-class medicine for the treatment of COVID-19 pneumonia and pathogen-induced ARDS, today announced the formation of a Clinical and Scientific Advisory Board. The Board is composed of key opinion leaders in their respective fields of medicine and

Bruker Corporation (Nasdaq: BRKR) today announced that it is adding a virtual meeting option to its 2020 Annual Meeting of Stockholders as a result of continuing concerns surrounding the COVID-19 pandemic. The Annual Meeting will be held on Thursday, May 21, 2020 at 10:00 a.m., Eastern Time, at the offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110. However, stockholders are str

Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, introduces the Slimplicity® HP Anterior Cervical Plating (ACP) System, which enables surgeons to accommodate diverse patient anatomies and pathologies with low profile constrained, semi-constrained or hybrid constructs.